Lewy Body Dementias
This PIA was established in April 2019.
Chair: Dag Aarsland
Vice Chair: Jim Leverenz
Programs Chair: Laura Bonanni
Communications Chair: TBA
Executive Committee Member: Bradley Boeve
Lewy Body Dementias (LBD) contribute to approximately 20% of dementia cases and are often underdiagnosed or misdiagnosed, thus leading to either no treatment or incorrect treatment. In addition, research into LBD has lagged far behind that of AD and others. This PIA’s vision is to disseminate information about LBD (including MCI) to public and medical communities and increase research efforts by joining forces and collaborate worldwide. An additional goal is foster professional development, mentoring opportunities and networking skills to colleagues and trainees in the arena of LBD and to policy advocates.